| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/25/2004 | WO2004024767A1 Immunoassays for specific determination of scca isoforms |
| 03/25/2004 | WO2004024758A1 Parathyroid hormone-like polypeptides |
| 03/25/2004 | WO2004024752A1 Method of purifying protein |
| 03/25/2004 | WO2004024750A2 Cd44-binding ligands |
| 03/25/2004 | WO2004024748A2 High affinity monoclonal antibody for recognizing the progesterone receptor (pr) and method for creating the antibody |
| 03/25/2004 | WO2004024747A2 High affinity monoclonal antibody for recognizing the estrogen receptor (er) and method for creating the antibody |
| 03/25/2004 | WO2004024746A2 Therapeutic anti-bgp(c-cam1) antibodies and uses thereof |
| 03/25/2004 | WO2004024098A2 Method for the treatment of nephritis using anti-pdgf-dd antibodies |
| 03/25/2004 | WO2004024097A2 Compositions and methods for the treatment of immune related diseases |
| 03/25/2004 | WO2004024090A2 Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence |
| 03/25/2004 | WO2004024084A2 Rb pahtway and chromatin remodeling genes that antagonize let-60 ras signaling |
| 03/25/2004 | WO2004024077A2 Novel composition and methods for the treatment of psoriasis |
| 03/25/2004 | WO2004024076A2 Novel compositions and methods for the treatment of immune related diseases |
| 03/25/2004 | WO2004024075A2 Chemokine receptor antagonists as therapeutic agents |
| 03/25/2004 | WO2004024068A2 Novel composition and methods for the treatment of immune related diseases |
| 03/25/2004 | WO2004024064A2 Compositions and methods for the diagnosis and treatment of tumor |
| 03/25/2004 | WO2004024063A2 Compositions and methods for the diagnosis and treatment of tumor |
| 03/25/2004 | WO2004018511A3 Composite peptide compounds for diagnosis and treatment of diseases caused by prion proteins |
| 03/25/2004 | WO2004011500A3 Specific isotype antibodies of secretion-excretion anti-antigens of leishmania sp of promastigote or amastigote forms used as protection, resistance and curing markers of mammals to leishmaniases and to intracellular pathogenic micro-organism infections, and as immunotherapeutic effectors |
| 03/25/2004 | WO2003106640A3 Cell targeting methods and compositions |
| 03/25/2004 | WO2003095968A3 Method for simultaneously detecting an antigen and an antibody of an infectious microorganism |
| 03/25/2004 | WO2003092624A3 Use of heat shock proteins to enhance efficacy of antibody therapeutics |
| 03/25/2004 | WO2003092610A3 Methods of using cytokine antagonists to treat hiv infection and aids |
| 03/25/2004 | WO2003088911A3 Universal libraries for immunoglobulins |
| 03/25/2004 | WO2003087340A3 Antibodies that bind to integrin alpha-v-beta-6 and methods of use thereof |
| 03/25/2004 | WO2003084565A3 Ve-ptp as regulator of ve-cadherin mediated processes or disorders |
| 03/25/2004 | WO2003083064A3 Chimeric pancreas |
| 03/25/2004 | WO2003081993A3 Transgenic aves producing human polyclonal antibodies |
| 03/25/2004 | WO2003081992A3 The functional disruption of avian immunoglobulin genes |
| 03/25/2004 | WO2003076946A3 Detection of specific nitrated protein markers |
| 03/25/2004 | WO2003076472A3 Neoplasm specific antibodies and uses thereof |
| 03/25/2004 | WO2003075741A9 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE |
| 03/25/2004 | WO2003074551A3 Conjugates of therapeutic or cytotoxic agents and biologically active peptides |
| 03/25/2004 | WO2003072804A3 Nanostructures containing pilin protein |
| 03/25/2004 | WO2003054156A3 Novel g proein-coupled receptor, gave7 |
| 03/25/2004 | WO2003051923A3 Novel g-protein coupled receptors and dna sequences thereof |
| 03/25/2004 | WO2003033680A3 Kinases and phosphatases |
| 03/25/2004 | WO2003031475A3 Antibodies against kdr, their production and uses |
| 03/25/2004 | WO2003020215A3 Methods of treating mycocardial event related coditions with thymosin beta 4 |
| 03/25/2004 | WO2003014731B1 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 03/25/2004 | WO2003000941A3 Polypeptides having cellobiohydrolase i activity and polynucleotides encoding same |
| 03/25/2004 | WO2002102829A3 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
| 03/25/2004 | WO2002085093A3 Replikin peptides and uses thereof |
| 03/25/2004 | WO2002083859A8 Surface proteins of streptococcus pyogenes |
| 03/25/2004 | WO2002079492A8 Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators |
| 03/25/2004 | WO2002072832A3 Therapeutic binding molecules |
| 03/25/2004 | WO2002063006A3 Receptors and membrane-associated proteins |
| 03/25/2004 | WO2002046434A3 Plasmid vectors |
| 03/25/2004 | WO2002034288A8 Vaccine for treating allergy |
| 03/25/2004 | WO2002017899A3 Regulation of angiogenesis via modulation of edg receptor mediated signal transduction comprising sphingosine-1-phosphate administration |
| 03/25/2004 | WO2001092470A3 Dna expression vectors and methods of use |
| 03/25/2004 | US20040060079 Method of controlling character of monocotyledon by modification and/or overexpression of cytochrome P450 monooxygenase gene involved in brassinosteroid biosynthesis and monocotyledon modified by the gene |
| 03/25/2004 | US20040059096 Immunoglobulin for preventing shellfish poisoning |
| 03/25/2004 | US20040059087 Peptide nucleic acids |
| 03/25/2004 | US20040058870 Reduce blood glucose concentration; antidiabetic agent; respiratory system disorders |
| 03/25/2004 | US20040058863 Genetic engineered polypeptide; influenza vaccine, gramnegative bacteria; induce immunology response |
| 03/25/2004 | US20040058851 Specific autoimmune reactions against isomerised/optically inverted epitopes: application for diagnosis of autoimmune diseases |
| 03/25/2004 | US20040058849 Fibroblast growth factor receptors and methods for their use |
| 03/25/2004 | US20040058445 Transgenic lymphocyte culture capable of inducing tumor destructive immunological response; immunotherapy |
| 03/25/2004 | US20040058424 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/25/2004 | US20040058414 Preparing antibody capable of binding and inhibiting activity of interleukin-2 and receptor, herpes viral epitopes and interferon receptors; diagnosis and treatment of viral and autoimmune diseases |
| 03/25/2004 | US20040058411 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/25/2004 | US20040058400 Multivalent and multispecific binding proteins, their manufacture and use |
| 03/25/2004 | US20040058398 Pancreatic progenitor cells and methods for isolating the same |
| 03/25/2004 | US20040058397 Monoclonal antibody for identifying and recovering mesenchymal stem cells; hematopoietic stem cell proliferation, maturation and differentiation |
| 03/25/2004 | US20040058394 Humanized anti-LT-beta-R antibodies |
| 03/25/2004 | US20040058393 Monoclonal antibodies which can transduce agonist signal into cells for treatment and prevention of cancer, inflammation, hormone and blood disorders |
| 03/25/2004 | US20040058383 Using concentration of human luteinizing hormone (hLH) to prognose and predict onset of menopause; evaluating efficacy of hormone replacement therapy |
| 03/25/2004 | US20040058371 Novel natural antibacterial peptide, the nucleotide sequence encoding it and the use thereof |
| 03/25/2004 | US20040058366 Comprises DNA coding brain-muscle-arnt-like protein 2 (BMAL2) for diagnosis and treatment of circadian rythm disorders |
| 03/25/2004 | US20040058365 Molecules for disease detection and treatment |
| 03/25/2004 | US20040058355 Comprises nucleotide sequences coding membrane proteins for diagnosis and treatment of brain, breast disorders, colon, kidney, inflammatory, brain and urogenital disorders |
| 03/25/2004 | US20040058353 Comprises nucleotide sequences coding transport proteins for diagnosis and treatment of pain, psychotic, eating and nervous system disorders |
| 03/25/2004 | US20040058342 Comprises serine protease for diagnosis, prognosis and treatment of cell proliferative disorders |
| 03/25/2004 | US20040058324 Gene sp17 inhibiting lesion formation in plant and utilization thereof |
| 03/25/2004 | US20040058321 Comprises nucleotide sequences coding transforming growth factor binding proteins for diagnosis and treatment of osteoporosis and osteopenia |
| 03/25/2004 | US20040058319 Comprises nucleotide sequences coding urogenital polypeptide for diagnosis and treatment cancer |
| 03/25/2004 | US20040058318 Transcripton factor comprising tyrosine kinase and interferon binding domains for diagnosis and treatment of autoimmune and immune response disorders; imunosuppressants |
| 03/25/2004 | US20040057968 T cell binding ligand peptides, peptide constructs containing same and use thereof for treatment of immunological disorders |
| 03/25/2004 | US20040057959 Recombitope peptides |
| 03/25/2004 | US20040057957 Agent for the treatment and/or prophylaxis of microcirculatory disorders |
| 03/25/2004 | US20040057956 Antibodies binding to RSATEEEPPNDD or DVEDSYGQQWTYEQR peptides (or isoforms/derivatives thereof) of alpha-subunit of (Na++K+)-ATPase, are highly inotropic; both antibodies and peptides are important for treatment of heart failure |
| 03/25/2004 | US20040057954 Tumor necrosis factor antagonists and their use in endometriosis |
| 03/25/2004 | US20040057953 Modified peptides as therapeutic agents |
| 03/25/2004 | US20040057952 Where antibodies and antibody fragments recognize extracellular epitopes of plasma membrane proteins that are not released into the extracellular fluid; methods for detection, monitoring and treatment of cancer |
| 03/25/2004 | US20040057951 Co-administration of a thrombolytic and an anti-CD18 antibody in stroke |
| 03/25/2004 | US20040057950 Overexpression of which can lead to tumorigenesis; useful in treatment of tumors of breast, lung, colon, kidney, bladder, head and neck, ovary, prostate, and brain |
| 03/25/2004 | US20040057902 For use in diagnosis and therapy |
| 03/25/2004 | CA2544124A1 Antibodies and methods for generating genetically altered antibodies with high affinity |
| 03/25/2004 | CA2500462A1 Polyclonal antibodies, preparation method thereof and use of same |
| 03/25/2004 | CA2499207A1 Method for the treatment of nephritis using anti-pdgf-dd antibodies |
| 03/25/2004 | CA2499130A1 Methods for regulating cancer |
| 03/25/2004 | CA2499075A1 Production of bispecific molecules using polyethylene glycol linkers |
| 03/25/2004 | CA2498928A1 Rb pathway and chromatin remodeling genes that antagonize let-60 ras signaling |
| 03/25/2004 | CA2498784A1 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
| 03/25/2004 | CA2498778A1 Antibodies that recognize hyperproliferative cells and methods of making and using same |
| 03/25/2004 | CA2498771A1 2',5'-oligoadenylate phosphodiesterase |
| 03/25/2004 | CA2498524A1 Immunoassays for specific determination of scca isoforms |
| 03/25/2004 | CA2498523A1 Human cd3-specific antibody with immunosuppressive properties |
| 03/25/2004 | CA2498407A1 Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence |